About this trial
STROBERRY Study is a Prospective, monocentric, randomized, open-label study assessing the contribution of telemedicine, in addition to standard follow-up, strengthening an Obesity program in Berry (France). The principal objective is to study the effectiveness of a follow-up reinforced with telemedicine in addition to the standard multidisciplinary annual follow-up on the rate of patients lost to follow-up after initial or second line management in a multidisciplinary bariatric medical program
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Woman or Male aged from 18 to 60 years old included
Patient in obesity (BMI> or = 30)
Patient who has completed a multidisciplinary medical program for obesity management, as a first- or second-line intention (after initial obesity management) at the investigating center
Affiliation to a social security scheme
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Quarterly remote motivational interviews
Other interventionRemote motivational interview will be in the form of quarterly telephone call (at 3, 6 and 9 months after the start of annual follow up; the patient is seen again at 12 months as part of the annual follow-up) and this for 4 years. It will be performed by medical staff trained in motivational interviewing and who have completed at least 40 hours training in therapeutic education
Treatment groups
Trial outcomes
Primary outcomes
Rates of patients lost to follow up
Rates of patients lost to follow up measured in both arms and compared 4 years after randomization
Secondary outcomes
The evolution of quality of life, self-esteem and perceived health compared to baseline
The evolution of quality of life, self-esteem and perceived health will be measured using the Duke questionnaire, and will be assessed at standard annual visits at 1, 2, 3 and 4 years after randomization
Rate of patients lost to follow-up will be assessed at standard annual visits at 1, 2 and 3 years after randomization
Rate of patients lost to follow-up will be assessed at standard annual visits at 1, 2 and 3 years after randomization
Change in waist circumference (cm) compared with the baseline measurement will be assessed at standard annual visits at 1, 2, 3 and 4 years after randomization.
Change in waist circumference (cm) compared with the baseline measurement will be assessed at standard annual visits at 1, 2, 3 and 4 years after randomization.
This trial is not recruiting at the moment. You can still explore other options: